BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gorini S, Marzolla V, Mammi C, Armani A, Caprio M. Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease. Biomolecules 2018;8:E96. [PMID: 30231508 DOI: 10.3390/biom8030096] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Feraco A, Marzolla V, Scuteri A, Armani A, Caprio M. Mineralocorticoid Receptors in Metabolic Syndrome: From Physiology to Disease. Trends Endocrinol Metab 2020;31:205-17. [PMID: 31843490 DOI: 10.1016/j.tem.2019.11.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
2 Martínez-Martínez E, Souza-Neto FV, Jiménez-González S, Cachofeiro V. Oxidative Stress and Vascular Damage in the Context of Obesity: The Hidden Guest. Antioxidants (Basel) 2021;10:406. [PMID: 33800427 DOI: 10.3390/antiox10030406] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Matsumoto T, Doi S, Nakashima A, Ike T, Sasaki K, Masaki T. Upregulation of Mineralocorticoid Receptor Contributes to Development of Salt-Sensitive Hypertension after Ischemia-Reperfusion Injury in Rats. Int J Mol Sci 2022;23:7831. [PMID: 35887178 DOI: 10.3390/ijms23147831] [Reference Citation Analysis]
4 Lopez AG, Duparc C, Wils J, Naccache A, Castanet M, Lefebvre H, Louiset E. Steroidogenic cell microenvironment and adrenal function in physiological and pathophysiological conditions. Mol Cell Endocrinol 2021;535:111377. [PMID: 34216641 DOI: 10.1016/j.mce.2021.111377] [Reference Citation Analysis]
5 Leader CJ, Wilkins GT, Walker RJ. The effect of spironolactone on cardiac and renal fibrosis following myocardial infarction in established hypertension in the transgenic Cyp1a1Ren2 rat. PLoS One 2021;16:e0260554. [PMID: 34843581 DOI: 10.1371/journal.pone.0260554] [Reference Citation Analysis]
6 Gorini S, Kim SK, Infante M, Mammi C, La Vignera S, Fabbri A, Jaffe IZ, Caprio M. Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging. Front Endocrinol (Lausanne) 2019;10:584. [PMID: 31507534 DOI: 10.3389/fendo.2019.00584] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
7 Canonica J, Mehanna C, Bonnard B, Jonet L, Gelize E, Jais JP, Jaisser F, Zhao M, Behar-Cohen F. Effect of acute and chronic aldosterone exposure on the retinal pigment epithelium-choroid complex in rodents. Exp Eye Res 2019;187:107747. [PMID: 31394103 DOI: 10.1016/j.exer.2019.107747] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
8 Brandt-Jacobsen NH, Lav Madsen P, Johansen ML, Rasmussen JJ, Forman JL, Holm MR, Rye Jørgensen N, Faber J, Rossignol P, Schou M, Kistorp C. Mineralocorticoid Receptor Antagonist Improves Cardiac Structure in Type 2 Diabetes: Data From the MIRAD Trial. JACC Heart Fail 2021;9:550-8. [PMID: 34325885 DOI: 10.1016/j.jchf.2021.02.016] [Reference Citation Analysis]
9 Barros ER, Rigalli JP, Tapia-Castillo A, Vecchiola A, Young MJ, Hoenderop JGJ, Bindels RJM, Fardella CE, Carvajal CA. Proteomic Profile of Urinary Extracellular Vesicles Identifies AGP1 as a Potential Biomarker of Primary Aldosteronism. Endocrinology 2021;162:bqab032. [PMID: 33580265 DOI: 10.1210/endocr/bqab032] [Reference Citation Analysis]